Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample.

The market is mainly driven by the significant applications of Cancer Stem Cells in various end use industries. The expanding demands from the Breast Cancer Diagnosis and Treatment, Prostate Cancer Diagnosis and Treatment, Colorectal Cancer Diagnosis and Treatment and Lung Cancer Diagnosis and Treatment, are propelling Cancer Stem Cells market. Cell Culturing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cell Separation segment is estimated at % CAGR for the next seven-year period.

Over the past few years, stem cells are being successfully utilized in immuno-reconstitution and for replenishment of blood after tumor development or after tumor treatment.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Stem Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Cancer Stem Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Cancer Stem Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Stem Cells sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Cancer Stem Cells covered in this report include Thermo Fisher Scientific, Abbvie, Merck Kgaa, Bionomics, Lonza, Stemline Therapeutics, Miltenyi Biotec, Promocell and Macrogenics, etc.

The global Cancer Stem Cells market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Thermo Fisher Scientific

Abbvie

Merck Kgaa

Bionomics

Lonza

Stemline Therapeutics

Miltenyi Biotec

Promocell

Macrogenics

Oncomed Pharmaceuticals

Irvine Scientific

Stemcell Technologies

Sino Biological

Biotime

Scope of Cancer Stem Cells - Market Report

Report Metric	Details
Report Name	Cancer Stem Cells - Market
Forecasted market size in 2029	US$ 1917.8 million
CAGR	12.0%
Forecasted years	2023 - 2029
Global Cancer Stem Cells market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Stem Cells market, Segment by Type:	Cell Culturing Cell Separation Cell Analysis Molecular Analysis Others
Global Cancer Stem Cells market, by Application	Breast Cancer Diagnosis and Treatment Prostate Cancer Diagnosis and Treatment Colorectal Cancer Diagnosis and Treatment Lung Cancer Diagnosis and Treatment Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cancer Stem Cells companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Cancer Stem Cells - Market size in 2029?

Ans: The Cancer Stem Cells - Market size in 2029 will be US$ 1917.8 million.

What are the Application segmentation covered in the Cancer Stem Cells - Market report?

Ans: The Applications covered in the Cancer Stem Cells - Market report are Breast Cancer Diagnosis and Treatment, Prostate Cancer Diagnosis and Treatment, Colorectal Cancer Diagnosis and Treatment, Lung Cancer Diagnosis and Treatment, Others

What are the Type segmentation covered in the Cancer Stem Cells - Market report?

Ans: The Types covered in the Cancer Stem Cells - Market report are Cell Culturing, Cell Separation, Cell Analysis, Molecular Analysis, Others

1 Market Overview of Cancer Stem Cells

1.1 Cancer Stem Cells Market Overview

1.1.1 Cancer Stem Cells Product Scope

1.1.2 Cancer Stem Cells Market Status and Outlook

1.2 Global Cancer Stem Cells Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Cancer Stem Cells Market Size by Region (2018-2029)

1.4 Global Cancer Stem Cells Historic Market Size by Region (2018-2023)

1.5 Global Cancer Stem Cells Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Cancer Stem Cells Market Size (2018-2029)

1.6.1 North America Cancer Stem Cells Market Size (2018-2029)

1.6.2 Europe Cancer Stem Cells Market Size (2018-2029)

1.6.3 Asia-Pacific Cancer Stem Cells Market Size (2018-2029)

1.6.4 Latin America Cancer Stem Cells Market Size (2018-2029)

1.6.5 Middle East & Africa Cancer Stem Cells Market Size (2018-2029)

2 Cancer Stem Cells Market by Type

2.1 Introduction

2.1.1 Cell Culturing

2.1.2 Cell Separation

2.1.3 Cell Analysis

2.1.4 Molecular Analysis

2.1.5 Others

2.2 Global Cancer Stem Cells Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Cancer Stem Cells Historic Market Size by Type (2018-2023)

2.2.2 Global Cancer Stem Cells Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Cancer Stem Cells Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Cancer Stem Cells Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Cancer Stem Cells Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Cancer Stem Cells Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Cancer Stem Cells Revenue Breakdown by Type (2018-2029)

3 Cancer Stem Cells Market Overview by Application

3.1 Introduction

3.1.1 Breast Cancer Diagnosis and Treatment

3.1.2 Prostate Cancer Diagnosis and Treatment

3.1.3 Colorectal Cancer Diagnosis and Treatment

3.1.4 Lung Cancer Diagnosis and Treatment

3.1.5 Others

3.2 Global Cancer Stem Cells Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Cancer Stem Cells Historic Market Size by Application (2018-2023)

3.2.2 Global Cancer Stem Cells Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Cancer Stem Cells Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Cancer Stem Cells Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Cancer Stem Cells Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Cancer Stem Cells Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Cancer Stem Cells Revenue Breakdown by Application (2018-2029)

4 Cancer Stem Cells Competition Analysis by Players

4.1 Global Cancer Stem Cells Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Stem Cells as of 2022)

4.3 Date of Key Players Enter into Cancer Stem Cells Market

4.4 Global Top Players Cancer Stem Cells Headquarters and Area Served

4.5 Key Players Cancer Stem Cells Product Solution and Service

4.6 Competitive Status

4.6.1 Cancer Stem Cells Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Thermo Fisher Scientific

5.1.1 Thermo Fisher Scientific Profile

5.1.2 Thermo Fisher Scientific Main Business

5.1.3 Thermo Fisher Scientific Cancer Stem Cells Products, Services and Solutions

5.1.4 Thermo Fisher Scientific Cancer Stem Cells Revenue (US$ Million) & (2018-2023)

5.1.5 Thermo Fisher Scientific Recent Developments

5.2 Abbvie

5.2.1 Abbvie Profile

5.2.2 Abbvie Main Business

5.2.3 Abbvie Cancer Stem Cells Products, Services and Solutions

5.2.4 Abbvie Cancer Stem Cells Revenue (US$ Million) & (2018-2023)

5.2.5 Abbvie Recent Developments

5.3 Merck Kgaa

5.3.1 Merck Kgaa Profile

5.3.2 Merck Kgaa Main Business

5.3.3 Merck Kgaa Cancer Stem Cells Products, Services and Solutions

5.3.4 Merck Kgaa Cancer Stem Cells Revenue (US$ Million) & (2018-2023)

5.3.5 Bionomics Recent Developments

5.4 Bionomics

5.4.1 Bionomics Profile

5.4.2 Bionomics Main Business

5.4.3 Bionomics Cancer Stem Cells Products, Services and Solutions

5.4.4 Bionomics Cancer Stem Cells Revenue (US$ Million) & (2018-2023)

5.4.5 Bionomics Recent Developments

5.5 Lonza

5.5.1 Lonza Profile

5.5.2 Lonza Main Business

5.5.3 Lonza Cancer Stem Cells Products, Services and Solutions

5.5.4 Lonza Cancer Stem Cells Revenue (US$ Million) & (2018-2023)

5.5.5 Lonza Recent Developments

5.6 Stemline Therapeutics

5.6.1 Stemline Therapeutics Profile

5.6.2 Stemline Therapeutics Main Business

5.6.3 Stemline Therapeutics Cancer Stem Cells Products, Services and Solutions

5.6.4 Stemline Therapeutics Cancer Stem Cells Revenue (US$ Million) & (2018-2023)

5.6.5 Stemline Therapeutics Recent Developments

5.7 Miltenyi Biotec

5.7.1 Miltenyi Biotec Profile

5.7.2 Miltenyi Biotec Main Business

5.7.3 Miltenyi Biotec Cancer Stem Cells Products, Services and Solutions

5.7.4 Miltenyi Biotec Cancer Stem Cells Revenue (US$ Million) & (2018-2023)

5.7.5 Miltenyi Biotec Recent Developments

5.8 Promocell

5.8.1 Promocell Profile

5.8.2 Promocell Main Business

5.8.3 Promocell Cancer Stem Cells Products, Services and Solutions

5.8.4 Promocell Cancer Stem Cells Revenue (US$ Million) & (2018-2023)

5.8.5 Promocell Recent Developments

5.9 Macrogenics

5.9.1 Macrogenics Profile

5.9.2 Macrogenics Main Business

5.9.3 Macrogenics Cancer Stem Cells Products, Services and Solutions

5.9.4 Macrogenics Cancer Stem Cells Revenue (US$ Million) & (2018-2023)

5.9.5 Macrogenics Recent Developments

5.10 Oncomed Pharmaceuticals

5.10.1 Oncomed Pharmaceuticals Profile

5.10.2 Oncomed Pharmaceuticals Main Business

5.10.3 Oncomed Pharmaceuticals Cancer Stem Cells Products, Services and Solutions

5.10.4 Oncomed Pharmaceuticals Cancer Stem Cells Revenue (US$ Million) & (2018-2023)

5.10.5 Oncomed Pharmaceuticals Recent Developments

5.11 Irvine Scientific

5.11.1 Irvine Scientific Profile

5.11.2 Irvine Scientific Main Business

5.11.3 Irvine Scientific Cancer Stem Cells Products, Services and Solutions

5.11.4 Irvine Scientific Cancer Stem Cells Revenue (US$ Million) & (2018-2023)

5.11.5 Irvine Scientific Recent Developments

5.12 Stemcell Technologies

5.12.1 Stemcell Technologies Profile

5.12.2 Stemcell Technologies Main Business

5.12.3 Stemcell Technologies Cancer Stem Cells Products, Services and Solutions

5.12.4 Stemcell Technologies Cancer Stem Cells Revenue (US$ Million) & (2018-2023)

5.12.5 Stemcell Technologies Recent Developments

5.13 Sino Biological

5.13.1 Sino Biological Profile

5.13.2 Sino Biological Main Business

5.13.3 Sino Biological Cancer Stem Cells Products, Services and Solutions

5.13.4 Sino Biological Cancer Stem Cells Revenue (US$ Million) & (2018-2023)

5.13.5 Sino Biological Recent Developments

5.14 Biotime

5.14.1 Biotime Profile

5.14.2 Biotime Main Business

5.14.3 Biotime Cancer Stem Cells Products, Services and Solutions

5.14.4 Biotime Cancer Stem Cells Revenue (US$ Million) & (2018-2023)

5.14.5 Biotime Recent Developments

6 North America

6.1 North America Cancer Stem Cells Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe Cancer Stem Cells Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Cancer Stem Cells Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Cancer Stem Cells Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Cancer Stem Cells Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Cancer Stem Cells Market Dynamics

11.1 Cancer Stem Cells Industry Trends

11.2 Cancer Stem Cells Market Drivers

11.3 Cancer Stem Cells Market Challenges

11.4 Cancer Stem Cells Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Thermo Fisher Scientific

Stemline Therapeutics

Miltenyi Biotec

PromoCell

MacroGenics Inc

Oncomed Pharmaceuticals

Irvine Scientific

StemCell Technologies

Sino Biological

BioTime

List of Tables

Table 1. Global Market Cancer Stem Cells Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Cancer Stem Cells Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Cancer Stem Cells Market Size Share by Region (2018-2023)

Table 4. Global Cancer Stem Cells Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Cancer Stem Cells Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Cancer Stem Cells Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Cancer Stem Cells Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Cancer Stem Cells Revenue Market Share by Type (2018-2023)

Table 9. Global Cancer Stem Cells Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Cancer Stem Cells Revenue Market Share by Type (2024-2029)

Table 11. North America Cancer Stem Cells Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Cancer Stem Cells Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Cancer Stem Cells Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Cancer Stem Cells Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Cancer Stem Cells Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Cancer Stem Cells Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Cancer Stem Cells Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Cancer Stem Cells Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Cancer Stem Cells Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Cancer Stem Cells Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Cancer Stem Cells Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Cancer Stem Cells Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Cancer Stem Cells Revenue Market Share by Application (2018-2023)

Table 24. Global Cancer Stem Cells Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Cancer Stem Cells Revenue Market Share by Application (2024-2029)

Table 26. North America Cancer Stem Cells Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Cancer Stem Cells Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Cancer Stem Cells Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Cancer Stem Cells Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Cancer Stem Cells Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Cancer Stem Cells Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Cancer Stem Cells Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Cancer Stem Cells Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Cancer Stem Cells Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Cancer Stem Cells Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Cancer Stem Cells Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Cancer Stem Cells Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Stem Cells as of 2022)

Table 39. Date of Key Players Enter into Cancer Stem Cells Market

Table 40. Global Cancer Stem Cells Key Players Headquarters and Area Served

Table 41. Cancer Stem Cells Product Solution and Service

Table 42. Global Cancer Stem Cells Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Thermo Fisher Scientific Basic Information List

Table 45. Thermo Fisher Scientific Description and Business Overview

Table 46. Thermo Fisher Scientific Cancer Stem Cells Products, Services and Solutions

Table 47. Revenue (US$ Million) in Cancer Stem Cells Business of Thermo Fisher Scientific (2018-2023)

Table 48. Thermo Fisher Scientific Recent Developments

Table 49. Abbvie Basic Information List

Table 50. Abbvie Description and Business Overview

Table 51. Abbvie Cancer Stem Cells Products, Services and Solutions

Table 52. Revenue (US$ Million) in Cancer Stem Cells Business of Abbvie (2018-2023)

Table 53. Abbvie Recent Developments

Table 54. Merck Kgaa Basic Information List

Table 55. Merck Kgaa Description and Business Overview

Table 56. Merck Kgaa Cancer Stem Cells Products, Services and Solutions

Table 57. Revenue (US$ Million) in Cancer Stem Cells Business of Merck Kgaa (2018-2023)

Table 58. Merck Kgaa Recent Developments

Table 59. Bionomics Basic Information List

Table 60. Bionomics Description and Business Overview

Table 61. Bionomics Cancer Stem Cells Products, Services and Solutions

Table 62. Revenue (US$ Million) in Cancer Stem Cells Business of Bionomics (2018-2023)

Table 63. Bionomics Recent Developments

Table 64. Lonza Basic Information List

Table 65. Lonza Description and Business Overview

Table 66. Lonza Cancer Stem Cells Products, Services and Solutions

Table 67. Revenue (US$ Million) in Cancer Stem Cells Business of Lonza (2018-2023)

Table 68. Lonza Recent Developments

Table 69. Stemline Therapeutics Basic Information List

Table 70. Stemline Therapeutics Description and Business Overview

Table 71. Stemline Therapeutics Cancer Stem Cells Products, Services and Solutions

Table 72. Revenue (US$ Million) in Cancer Stem Cells Business of Stemline Therapeutics (2018-2023)

Table 73. Stemline Therapeutics Recent Developments

Table 74. Miltenyi Biotec Basic Information List

Table 75. Miltenyi Biotec Description and Business Overview

Table 76. Miltenyi Biotec Cancer Stem Cells Products, Services and Solutions

Table 77. Revenue (US$ Million) in Cancer Stem Cells Business of Miltenyi Biotec (2018-2023)

Table 78. Miltenyi Biotec Recent Developments

Table 79. Promocell Basic Information List

Table 80. Promocell Description and Business Overview

Table 81. Promocell Cancer Stem Cells Products, Services and Solutions

Table 82. Revenue (US$ Million) in Cancer Stem Cells Business of Promocell (2018-2023)

Table 83. Promocell Recent Developments

Table 84. Macrogenics Basic Information List

Table 85. Macrogenics Description and Business Overview

Table 86. Macrogenics Cancer Stem Cells Products, Services and Solutions

Table 87. Revenue (US$ Million) in Cancer Stem Cells Business of Macrogenics (2018-2023)

Table 88. Macrogenics Recent Developments

Table 89. Oncomed Pharmaceuticals Basic Information List

Table 90. Oncomed Pharmaceuticals Description and Business Overview

Table 91. Oncomed Pharmaceuticals Cancer Stem Cells Products, Services and Solutions

Table 92. Revenue (US$ Million) in Cancer Stem Cells Business of Oncomed Pharmaceuticals (2018-2023)

Table 93. Oncomed Pharmaceuticals Recent Developments

Table 94. Irvine Scientific Basic Information List

Table 95. Irvine Scientific Description and Business Overview

Table 96. Irvine Scientific Cancer Stem Cells Products, Services and Solutions

Table 97. Revenue (US$ Million) in Cancer Stem Cells Business of Irvine Scientific (2018-2023)

Table 98. Irvine Scientific Recent Developments

Table 99. Stemcell Technologies Basic Information List

Table 100. Stemcell Technologies Description and Business Overview

Table 101. Stemcell Technologies Cancer Stem Cells Products, Services and Solutions

Table 102. Revenue (US$ Million) in Cancer Stem Cells Business of Stemcell Technologies (2018-2023)

Table 103. Stemcell Technologies Recent Developments

Table 104. Sino Biological Basic Information List

Table 105. Sino Biological Description and Business Overview

Table 106. Sino Biological Cancer Stem Cells Products, Services and Solutions

Table 107. Revenue (US$ Million) in Cancer Stem Cells Business of Sino Biological (2018-2023)

Table 108. Sino Biological Recent Developments

Table 109. Biotime Basic Information List

Table 110. Biotime Description and Business Overview

Table 111. Biotime Cancer Stem Cells Products, Services and Solutions

Table 112. Revenue (US$ Million) in Cancer Stem Cells Business of Biotime (2018-2023)

Table 113. Biotime Recent Developments

Table 114. North America Cancer Stem Cells Market Size by Country (2018-2023) & (US$ Million)

Table 115. North America Cancer Stem Cells Market Size by Country (2024-2029) & (US$ Million)

Table 116. Europe Cancer Stem Cells Market Size by Country (2018-2023) & (US$ Million)

Table 117. Europe Cancer Stem Cells Market Size by Country (2024-2029) & (US$ Million)

Table 118. Asia-Pacific Cancer Stem Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 119. Asia-Pacific Cancer Stem Cells Market Size by Region (2018-2023) & (US$ Million)

Table 120. Asia-Pacific Cancer Stem Cells Market Size by Region (2024-2029) & (US$ Million)

Table 121. Asia-Pacific Cancer Stem Cells Market Share by Region (2018-2023)

Table 122. Asia-Pacific Cancer Stem Cells Market Share by Region (2024-2029)

Table 123. Latin America Cancer Stem Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 124. Latin America Cancer Stem Cells Market Size by Country (2018-2023) & (US$ Million)

Table 125. Latin America Cancer Stem Cells Market Size by Country (2024-2029) & (US$ Million)

Table 126. Middle East & Africa Cancer Stem Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 127. Middle East & Africa Cancer Stem Cells Market Size by Country (2018-2023) & (US$ Million)

Table 128. Middle East & Africa Cancer Stem Cells Market Size by Country (2024-2029) & (US$ Million)

Table 129. Cancer Stem Cells Market Trends

Table 130. Cancer Stem Cells Market Drivers

Table 131. Cancer Stem Cells Market Challenges

Table 132. Cancer Stem Cells Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cancer Stem Cells Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Cancer Stem Cells Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Cancer Stem Cells Market Share by Regions: 2022 VS 2029

Figure 4. Global Cancer Stem Cells Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Cancer Stem Cells Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Cancer Stem Cells Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Cancer Stem Cells Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Cancer Stem Cells Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Cancer Stem Cells Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Cell Culturing

Figure 11. Global Cell Culturing Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Cell Separation

Figure 13. Global Cell Separation Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Product Picture of Cell Analysis

Figure 15. Global Cell Analysis Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 16. Product Picture of Molecular Analysis

Figure 17. Global Molecular Analysis Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 18. Product Picture of Others

Figure 19. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 20. Global Cancer Stem Cells Market Size Share by Type: 2022 & 2029

Figure 21. North America Cancer Stem Cells Revenue Market Share by Type (2018-2029)

Figure 22. Europe Cancer Stem Cells Revenue Market Share by Type (2018-2029)

Figure 23. Asia-Pacific Cancer Stem Cells Revenue Market Share by Type (2018-2029)

Figure 24. Latin America Cancer Stem Cells Revenue Market Share by Type (2018-2029)

Figure 25. Middle East and Africa Cancer Stem Cells Revenue Market Share by Type (2018-2029)

Figure 26. Breast Cancer Diagnosis and Treatment Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 27. Prostate Cancer Diagnosis and Treatment Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 28. Colorectal Cancer Diagnosis and Treatment Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 29. Lung Cancer Diagnosis and Treatment Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 30. Others Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 31. Global Cancer Stem Cells Market Size Share by Application: 2022 & 2029

Figure 32. North America Cancer Stem Cells Revenue Market Share by Application (2018-2029)

Figure 33. Europe Cancer Stem Cells Revenue Market Share by Application (2018-2029)

Figure 34. Asia-Pacific Cancer Stem Cells Revenue Market Share by Application (2018-2029)

Figure 35. Latin America Cancer Stem Cells Revenue Market Share by Application (2018-2029)

Figure 36. Middle East and Africa Cancer Stem Cells Revenue Market Share by Application (2018-2029)

Figure 37. Cancer Stem Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 38. Global Top 5 and Top 10 Players Cancer Stem Cells Market Share in 2022

Figure 39. North America Cancer Stem Cells Market Share by Country (2018-2029)

Figure 40. U.S. Cancer Stem Cells Market Size (2018-2029) & (US$ Million)

Figure 41. Canada Cancer Stem Cells Market Size (2018-2029) & (US$ Million)

Figure 42. Germany Cancer Stem Cells Market Size (2018-2029) & (US$ Million)

Figure 43. France Cancer Stem Cells Market Size (2018-2029) & (US$ Million)

Figure 44. U.K. Cancer Stem Cells Market Size (2018-2029) & (US$ Million)

Figure 45. Italy Cancer Stem Cells Market Size (2018-2029) & (US$ Million)

Figure 46. Russia Cancer Stem Cells Market Size (2018-2029) & (US$ Million)

Figure 47. Nordic Countries Cancer Stem Cells Market Size (2018-2029) & (US$ Million)

Figure 48. Asia-Pacific Cancer Stem Cells Market Share by Region (2018-2029)

Figure 49. China Cancer Stem Cells Market Size (2018-2029) & (US$ Million)

Figure 50. Japan Cancer Stem Cells Market Size (2018-2029) & (US$ Million)

Figure 51. South Korea Cancer Stem Cells Market Size (2018-2029) & (US$ Million)

Figure 52. Southeast Asia Cancer Stem Cells Market Size (2018-2029) & (US$ Million)

Figure 53. India Cancer Stem Cells Market Size (2018-2029) & (US$ Million)

Figure 54. Australia Cancer Stem Cells Market Size (2018-2029) & (US$ Million)

Figure 55. Latin America Cancer Stem Cells Market Share by Country (2018-2029)

Figure 56. Mexico Cancer Stem Cells Market Size (2018-2029) & (US$ Million)

Figure 57. Brazil Cancer Stem Cells Market Size (2018-2029) & (US$ Million)

Figure 58. Middle East & Africa Cancer Stem Cells Market Share by Country (2018-2029)

Figure 59. Turkey Cancer Stem Cells Market Size (2018-2029) & (US$ Million)

Figure 60. Saudi Arabia Cancer Stem Cells Market Size (2018-2029) & (US$ Million)

Figure 61. UAE Cancer Stem Cells Market Size (2018-2029) & (US$ Million)

Figure 62. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions